Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 06, 2016Vassiliki Papadimitrakopoulou, MD: Squamous cell carcinoma: Changing face of 1st and 2nd line therapyWebcast: 21st Annual Perspectives in Lung Cancer25 minPlay
December 06, 2016Barbara A. Burtness, MD: Advances in esophageal cancer: Current and future strategiesWebcast: 21st Annual Perspectives in Lung Cancer24 minPlay
December 06, 2016Vera Hirsh, MD, FRCP: How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLCWebcast: 21st Annual Perspectives in Lung Cancer18 minPlay
December 06, 2016Tracey L. Evans, MD: Managing T790-positive EGFR-mutated NSCLCWebcast: 21st Annual Perspectives in Lung Cancer19 minPlay
December 06, 2016Ranee Mehra, MD: Managing T790-negative EGFR-mutated NSCLCWebcast: 21st Annual Perspectives in Lung Cancer14 minPlay
December 06, 2016Corey J. Langer, MD, FACP: Targeting angiogenesis in NSCLCWebcast: 21st Annual Perspectives in Lung Cancer25 minPlay
December 06, 2016Vera Hirsh MD, FRCP: Bone metastases: Role of zoledronic acid, denosumab and other strategiesWebcast: 21st Annual Perspectives in Lung Cancer18 minPlay
December 06, 2016Beth Eaby-Sandy, MSN, CRNP: Communicating with patients and families: Managing expectations as hope and reality collideWebcast: 21st Annual Perspectives in Lung Cancer20 minPlay
December 06, 2016Philip D. Bonomi, MD: Combating cachexia: New approachesWebcast: 21st Annual Perspectives in Lung Cancer17 minPlay
December 06, 2016Pallavi Kumar, MD: How to conduct family meetings and end of life conversationsWebcast: 21st Annual Perspectives in Lung Cancer12 minPlay